Skip to main content
Clinical Trials/NL-OMON32306
NL-OMON32306Not yet recruitingNot Applicable

24-Hour ambulatory blood pressure monitoring in patients with malignancies enrolled in phase I oncological studies - ABPM in patients with malignancies

Slotervaartziekenhuis0 sites15 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational non invasive

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - enrolled in ongoing or future phase I studies of novel anti-cancer agents at the NKI-AVL
  • - scheduled to be hospitalized for at least a 24 hours during the phase I trial

Exclusion Criteria

  • - currently associated with essential hypertension, cardiovascular disease or renal impairment
  • - currently treated with drugs that are known to have an effect on the cardiovascular and/or the renovascular system

Investigators

Sponsor
Slotervaartziekenhuis

Similar Trials